Startups "Eureka" and "VitaPortal" announced a merger. Companies work at the interface of medicine and the Internet. The
Evrika group specializes in working with a professional medical audience on the Internet.
"VitaPortal" - a user online resource about health. After the merger, the shares of shareholders will be divided on a parity basis. The participants in the transaction expect that in three years the combined company will cost $ 20 million.
VitaPortal was launched in 2011 by the business incubator Fastlane Ventures (
FV ). During its existence, the startup has attracted $ 4.35 million investment. Investors of the project are venture funds
Prostor Capital and
Runa Capital , as well as business angel Esther Dyson, founder and CEO of
Life Sciences Angel Network Milena Adamyan and entrepreneur Alexey Kandikov. According to the company, the monthly audience of VitaPortal exceeds 1.6 million users.
Since 2010 Evrika Group has been developing online pharmaceutical and medical products. Professional information and educational resource for Evrika.ru doctors with an audience of over 49 thousand specialists is the main project of the company. Evrika has also developed a technology platform for continuous medical online education
Tsnmo.rf .
')
The founder and owner of the Eureka group is Alexander Ogandzhanyan. According to "SPARK-Interfax", the company's revenue in 2013 amounted to 4.7 million rubles, a net loss of 15 thousand rubles. Over the past year, the total revenue of the Evrika and VitaPortala groups has doubled compared with 2013. This year, the project management plans to go into profit.
“The medical IT segment remains one of the fastest growing, both in terms of attracting investment, as well as in terms of audience size and tool development. The newly created company has great growth potential - not only organic, but also through acquisitions, ”said Alexander Ogandzhanyan.
According to the consulting company
Mercom Capital Group , in 2014 financial support in the field of IT for medical startups doubled compared to 2013 and reached $ 4.7 billion. The number of transactions increased to 670. Many investors around the world consider digital medicine a promising direction.